Bristol Myers Squibb SWOT Analysis, Competitors & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Bristol Myers Squibb analyses the brand by its strengths, weaknesses, opportunities & threats. In Bristol Myers Squibb SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Bristol Myers Squibb to benchmark its business & performance as compared to the competitors. Bristol Myers Squibb is one of the leading brands in the pharma and healthcare sector.

The article below lists the Bristol Myers Squibb SWOT, competitors and includes its target market, segmentation, positioning & USP. Let us start the Bristol Myers Squibb SWOT Analysis:

SWOT Analysis of Bristol Myers Squibb

For Bristol Myers Squibb, SWOT analysis can help the brand focus on building upon its strengths and opportunities while addressing its weaknesses as well as threats to improve its market position.

Bristol Myers Squibb Strengths

The strengths of Bristol Myers Squibb looks at the key aspects of its business which gives it competitive advantage in the market. Some important factors in a brand's strengths include its financial position, experienced workforce, product uniqueness & intangible assets like brand value. Below are the Strengths in the SWOT Analysis of Bristol Myers Squibb :

1.Deliver new medicines regularly

2. Provide free medications to qualifying patients with financial problems in the U.S.

3. Employ 44000 people all over world, strong global footprint

4. Corporate strategy with the acquisition of many other companies

5. String of new technologies, alliances has strengthened the brand

6. Co-development and co-commercialization agreements with companies have boosted image

Bristol Myers Squibb Weaknesses

The weaknesses of a brand are certain aspects of its business which are it can improve to increase its position further. Certain weaknesses can be defined as attributes which the company is lacking or in which the competitors are better. Here are the weaknesses in the Bristol Myers Squibb SWOT Analysis:

1.Strong dependence on working with third parties to improve and enhance abilities

2. Substantial drop in sales for two key drugs: Plavix, a blood thinner, and Pravachol, a cholesterol-lowering drug.

3. Company layoffs and post retirement plans may affect employee relations.


Bristol Myers Squibb Opportunities

The opportunities for any brand can include areas of improvement to increase its business. A brand's opportunities can lie in geographic expansion, product improvements, better communication etc. Following are the opportunities in Bristol Myers Squibb SWOT Analysis:

1. Security technologies to make packaging and products less vulnerable to counterfeiting and to secure their movement within the supply chain

2. An integrated team addresses counterfeiting, product tampering, theft and diversion issues

3. Expand access to its products through strategic acquisitions & partnerships.

Bristol Myers Squibb Threats

The threats for any business can be factors which can negatively impact its business. Some factors like increased competitor activity, changing government policies, alternate products or services etc. can be threats. The threats in the SWOT Analysis of Bristol Myers Squibb are as mentioned:

1. The company acquires biotech companies, technology and expertise and hence a threat to its culture is infused ever more deeply.

2. Counterfeit drugs and product tampering, theft or diversion represent a threat

3. Pricing  pressures

4. Global economic slowdown


Bristol Myers Squibb Competitors

There are several brands in the market which are competing for the same set of customers. Below are the top 6 competitors of Bristol Myers Squibb:

1.AstraZeneca

2.Roche Holding

3.Novartis

4.Merck & Co.

5.Biogen

6.Teva Pharmaceutical

Hence this concludes the Bristol Myers Squibb SWOT analysis.

Continue reading more about the brand/company.

About Bristol Myers Squibb

Bristol Myers Squibb Overview
Parent Company

Bristol Myers Squibb

Category

Biopharmaceuticals

Sector

Pharma and Healthcare

Tagline/ Slogan

Together we can prevail

USP

Bristol-Myers Squibb is a global BioPharma company focused to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Bristol Myers Squibb STP
Segmentation

Diseases such as cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders

Target Market

Healthcare professionals, doctors, pharmacists

Positioning

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Browse marketing analysis of more brands and companies similar to Bristol Myers Squibb. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.

Continue Reading:


The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin